ZA200701399B - Alkylidene tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents - Google Patents

Alkylidene tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents

Info

Publication number
ZA200701399B
ZA200701399B ZA200701399A ZA200701399A ZA200701399B ZA 200701399 B ZA200701399 B ZA 200701399B ZA 200701399 A ZA200701399 A ZA 200701399A ZA 200701399 A ZA200701399 A ZA 200701399A ZA 200701399 B ZA200701399 B ZA 200701399B
Authority
ZA
South Africa
Prior art keywords
alkylidene
production
inflammatory agents
tetrahydronaphthalene derivatives
tetrahydronaphthalene
Prior art date
Application number
ZA200701399A
Other languages
English (en)
Inventor
Baeurle Stefan
Jaroch Stefan
Nguyen Duy
Schaecke Heike
Skuballa Werner
Berger Markus
Krolikiewicz Konrad
Rehwinkel
Hartmut
Schmees Norbert
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of ZA200701399B publication Critical patent/ZA200701399B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84—Nitrogen atoms
ZA200701399A 2004-09-09 2007-02-16 Alkylidene tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents ZA200701399B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004044680A DE102004044680B3 (de) 2004-09-09 2004-09-09 Alkyliden-Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer sowie diese enthaltende pharmazeutische Präparate

Publications (1)

Publication Number Publication Date
ZA200701399B true ZA200701399B (en) 2008-09-25

Family

ID=35517445

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200701399A ZA200701399B (en) 2004-09-09 2007-02-16 Alkylidene tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents

Country Status (25)

Country Link
EP (1) EP1786823B1 (xx)
JP (1) JP2008512416A (xx)
KR (1) KR20070050469A (xx)
CN (1) CN101065386A (xx)
AR (1) AR050733A1 (xx)
AT (1) ATE384069T1 (xx)
AU (1) AU2005281859A1 (xx)
BR (1) BRPI0515186A (xx)
CA (1) CA2577861A1 (xx)
DE (2) DE102004044680B3 (xx)
EA (1) EA200700550A1 (xx)
EC (1) ECSP077306A (xx)
ES (1) ES2301056T3 (xx)
GT (1) GT200500241A (xx)
IL (1) IL181832A0 (xx)
MX (1) MX2007002833A (xx)
NO (1) NO20071805L (xx)
PA (1) PA8644701A1 (xx)
PE (1) PE20060596A1 (xx)
RS (1) RS20070095A (xx)
SV (1) SV2006002220A (xx)
TW (1) TW200621703A (xx)
UY (1) UY29109A1 (xx)
WO (1) WO2006027236A1 (xx)
ZA (1) ZA200701399B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7638515B2 (en) 2003-10-08 2009-12-29 Bayer Schering Pharma Aktiengesellschaft Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
ES2279454T3 (es) 2003-10-08 2007-08-16 Bayer Schering Pharma Aktiengesellschaft Derivados de tetrahidronaftaleno sustituidos con 1-amino-2-oxi, procedimientos para su preparacion y su utilizacion como anti-inflamatorios.
US7662821B2 (en) 2003-10-08 2010-02-16 Bayer Schering Pharma Ag Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US20080153859A1 (en) 2004-04-05 2008-06-26 Hartmut Rehwinkel Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
DE102004063227A1 (de) * 2004-12-22 2006-07-06 Schering Ag Tricylische Aminoalkohole, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
EP1834948A1 (de) 2006-03-15 2007-09-19 Bayer Schering Pharma Aktiengesellschaft Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
EP1917963A1 (en) * 2006-10-31 2008-05-07 Bayer Schering Pharma Aktiengesellschaft Cyclic phenyl-substituted indazols, a process for their production and their use as anti-inflammatory agents
EP2129219A4 (en) * 2007-02-16 2012-08-29 Synta Pharmaceuticals Corp SUBSTITUTED FUSED CYCLE COMPOUNDS USED IN CASES OF INFLAMMATION OR IMMUNE DISORDERS
EP2072509A1 (en) 2007-12-18 2009-06-24 Bayer Schering Pharma Aktiengesellschaft 1-Aryl-1H-quinoline-2-ones: process for their production and their use as anti-inflammatory agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0800517A1 (en) * 1994-12-29 1997-10-15 Allergan Acetylenes disubstituted with a 5 or 8 substituted tetrahydronaphthyl or dihydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity
DE10038639A1 (de) * 2000-07-28 2002-02-21 Schering Ag Nichtsteroidale Entzündungshemmer
EA008830B1 (ru) * 2002-03-26 2007-08-31 Бёрингер Ингельхайм Фармасьютиклз, Инк. Миметики глюкокортикоидов, способы их получения, фармацевтические композиции и их применение
DE10215316C1 (de) * 2002-04-02 2003-12-18 Schering Ag Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer
ES2279454T3 (es) * 2003-10-08 2007-08-16 Bayer Schering Pharma Aktiengesellschaft Derivados de tetrahidronaftaleno sustituidos con 1-amino-2-oxi, procedimientos para su preparacion y su utilizacion como anti-inflamatorios.

Also Published As

Publication number Publication date
AR050733A1 (es) 2006-11-15
TW200621703A (en) 2006-07-01
EP1786823A1 (de) 2007-05-23
ECSP077306A (es) 2007-04-26
PA8644701A1 (es) 2006-07-03
RS20070095A (xx) 2008-11-28
DE102004044680B3 (de) 2006-06-08
EA200700550A1 (ru) 2007-10-26
IL181832A0 (en) 2007-07-04
DE502005002595D1 (de) 2008-03-06
ATE384069T1 (de) 2008-02-15
CA2577861A1 (en) 2006-03-16
MX2007002833A (es) 2007-07-09
AU2005281859A1 (en) 2006-03-16
UY29109A1 (es) 2006-03-31
WO2006027236A1 (de) 2006-03-16
KR20070050469A (ko) 2007-05-15
SV2006002220A (es) 2006-03-15
ES2301056T3 (es) 2008-06-16
BRPI0515186A (pt) 2008-07-22
PE20060596A1 (es) 2006-07-26
NO20071805L (no) 2007-06-07
CN101065386A (zh) 2007-10-31
JP2008512416A (ja) 2008-04-24
GT200500241A (es) 2006-08-17
EP1786823B1 (de) 2008-01-16

Similar Documents

Publication Publication Date Title
IL179758A (en) Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof and use of the same as medicaments
IL181832A0 (en) Alkylidene tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents
IL172899A0 (en) Heterocyclically substituted pentanol derivatives, method for the production thereof, and use thereof as anti-inflammatory agents
IL181012A0 (en) Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments
IL183060A0 (en) Tricyclic aminoalcohols, methods for producing the same and their use as anti-inflammatory agents
IL180874A0 (en) Substituted, bicyclic 8-pyrrolidinoxanthines, method for the production thereof and their use as medicaments
IL176913A0 (en) 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
AU2006274834A8 (en) Methods for preventing and treating metabolic disorders and new pyrazole-O-glycoside derivatives
IL177087A0 (en) Controlled-release pharmaceutical composition and method for producing the same
EP1967171A4 (en) SKIN PATCHES AND METHOD OF MANUFACTURE THEREOF
IL193155A0 (en) Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
IL178887A0 (en) Novel beta agonists, method for producing the same and their use as drugs
IL182505A0 (en) Purified phospholipid-non-steroidal, anti-inflammatory drug associated compositions and method for preparing and using same
ZA200706672B (en) 2,4-Diamino-pyridopyrimidine derivatives and their use as mTOR inhibitors
PL377741A1 (pl) Pochodne diarylocykloalkilowe, sposób ich wytwarzania i ich zastosowanie jako środka leczniczego
IL174975A0 (en) 2-phenyl-benzofuran derivatives, method for the production thereof and their use
PL366690A1 (en) New derivatives of 4,5,6,7-tetrabromobenzimidazole and method for their obtaining
HK1100946A1 (en) 1-a-HALO-2,2-DIFLUORO-2-DEOXY-D-RIBOFURANOSE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
PL380163A1 (pl) Sposób otrzymywania 1, 2-diaminopropanu i polipropylenoamin
IL181339A0 (en) Method for the production of diarylcycloalkyl derivatives
GB0625794D0 (en) Condom and process for producing the same
EP1781678A4 (en) 1 -? - HALOGEN-2,2-DIFLUOR-2-DESOXY-D-RIBOFURANOSEDERIVATE AND PROCESS FOR THE PRODUCTION THEREOF
IL187419A0 (en) Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents
EP1711189A4 (en) AZALIDE DERIVATIVES 8A 6,11-3C-BICYCLIC
IL178521A0 (en) Process for the preparation of substituted tetralin and substituted indane derivatives